Evidence map›Paper›PMID 24658054›Full record

ArticlePloS one2014

Regulation of pituitary MT1 melatonin receptor expression by gonadotrophin-releasing hormone (GnRH) and early growth response factor-1 (Egr-1): in vivo and in vitro studies.

Sung-Eun Bae, Ian K Wright, Cathy Wyse, Nathalie Samson-Desvignes, Pascale Le Blanc, Serge Laroche, David G Hazlerigg, Jonathan D Johnston

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Sung-Eun BaeFaculty of Health and Medical Science, University of Surrey, Guildford, Surrey, United Kingdom.
Ian K WrightFaculty of Health and Medical Science, University of Surrey, Guildford, Surrey, United Kingdom.
Cathy WyseSchool of Biological Sciences, University of Aberdeen, Aberdeen, United Kingdom; School of Veterinary Medicine, University of Glasgow, Glasgow, United Kingdom.
Nathalie Samson-DesvignesCentre de Neurosciences Paris-Sud, Centre National de la Recherche Scientifique, Univ. Paris-Sud, Orsay, France.
Pascale Le BlancCentre de Neurosciences Paris-Sud, Centre National de la Recherche Scientifique, Univ. Paris-Sud, Orsay, France.
Serge LarocheCentre de Neurosciences Paris-Sud, Centre National de la Recherche Scientifique, Univ. Paris-Sud, Orsay, France.
David G HazleriggSchool of Biological Sciences, University of Aberdeen, Aberdeen, United Kingdom; Department of Arctic and Marine Biology, Faculty of Biosciences Fisheries and Economy, University of Tromsø, Tromsø, Norway.
Jonathan D JohnstonFaculty of Health and Medical Science, University of Surrey, Guildford, Surrey, United Kingdom.
University of Surrey · GBUniversité Paris-Sud · FRCentre National de la Recherche Scientifique · FRUniversity of Aberdeen · GBUniversity of Glasgow · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F020309/1
6 · The paper itself

Abstract

Melatonin receptor expression exhibits profound developmental changes through poorly understood mechanisms. In mammals, a current model suggests that pubertal reactivation of gonadotrophin-releasing hormone (GnRH) secretion down-regulates MT1 melatonin receptors in pituitary gonadotroph cells, via the induction of early growth response factor-1 (EGR-1). Here we have examined this model by testing the hypotheses that inhibition of Mt1 expression by GnRH occurs directly in gonadotroph cells, can be reversed in adulthood by blockade of GnRH receptors, and requires EGR-1. We first confirmed the endogenous expression of Mt1 mRNA in the αT3-1 gonadotroph cell line. Stimulation of these cells with a GnRH agonist resulted in a rapid increase of Egr-1 mRNA expression, which peaked after 30-60 minutes, and a more prolonged elevation of nuclear EGR-1 immunoreactivity. Moreover, the GnRH agonist significantly decreased Mt1 mRNA. We then treated adult male rats with the GnRH antagonist cetrorelix or saline. After 4 weeks of daily injections, cetrorelix significantly reduced serum LH concentration and testis weight, with histological analysis confirming absence of spermatogenesis. Despite the successful inhibition of GnRH signalling, pituitary Mt1 expression was unchanged. Next we studied the proximal region of the rat Mt1 promoter. Consistent with previous work, over-expression of the transcription factor PITX-1 increased Mt1-luciferase reporter activity; this effect was dependent on the presence of consensus PITX-1 promoter binding regions. Over-expression of EGR-1 inhibited PITX-1-stimulated activity, even following mutation of the consensus EGR-1 binding site. Finally, we studied Egr1-/- mice and observed no difference in pituitary Mt1 expression between Egr1-/- and wild-type litter mates. This work demonstrates that GnRH receptor activation directly down-regulates Mt1 expression in gonadotroph cells. However, pituitary Mt1 expression in adults is unaltered by blockade of GnRH signalling or absence of EGR-1. Our data therefore suggest that melatonin receptor regulation by GnRH is not reversible in adulthood and doesn't require EGR-1.

Indexed as

AnimalsBinding SitesChlorocebus aethiopsCOS CellsEarly Growth Response Protein 1Gene Expression RegulationGonadotrophsGonadotropin-Releasing HormoneHormone AntagonistsMaleMicePaired Box Transcription FactorsPituitary GlandPromoter Regions, GeneticRatsRats, WistarcetrorelixEarly Growth Response Protein 1Gonadotropin-Releasing Hormonehomeobox protein PITX1Hormone AntagonistsPaired Box Transcription FactorsReceptor, Melatonin, MT1Receptors, LHRHRNA, Messenger

Identifiers

PMID24658054
PMCPMC3962332
OpenAlexW2073089461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.